NASDAQ · PPCB
Propanc Biopharma, Inc.
$1.86-$0.25 (-12.08%)
Propanc Biopharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.42% below the high.
Loading market information…
OTC · TPIA · USD
Stock price, earnings
Quote as of Feb 14, 2025, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Mycotopia Therapies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 89.44% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Mycotopia Therapies, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Mycotopia Therapies, Inc. specializes in the application of psychedelic compounds to address a range of mental health conditions. The company offers therapeutic interventions for ailments such as post-traumatic stress disorder (PTSD), severe anxiety, depression, and serotonin syndrome, in addition to providing support for palliative care. Headquartered in Aventura, Florida, Mycotopia Therapies, Inc. operates as a subsidiary of EHAVE, Inc.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:20 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1.86-$0.25 (-12.08%)
Propanc Biopharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.42% below the high.
$0.00-$0.00 (-90.0%)
RedHawk Holdings Corp.: Healthcare · Medical - Devices.
$0.00+$0.00 (+400.0%)
QuantRx Biomedical Corporation’s quoted price sits in the lower half of its reported 52-week range, 87.5% below the high.
$0.00+$0.00 (+29,900.0%)
Miravant Medical Technologies Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.03$0.00 (0.0%)
TRACON Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.7% below the high.
$0.00-$0.05 (-99.6%)
StatSure Diagnostic Systems, Inc.: Healthcare · Medical - Devices.
$0.00$0.00 (0.0%)
Cell Kinetics Ltd.: Healthcare · Medical - Devices.
$0.00$0.00 (0.0%)
PotNetwork Holdings, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
